Everotas 0.25 mg Tablet
$4.87
$3.79
Everotas 0.25 mg Tablet is a targeted anticancer therapy designed to combat advanced stages of various malignancies, including those affecting the pancreas, stomach, intestines, and lungs that are not amenable to surgical intervention. This medication works by disrupting the growth and spread of cancer cells, thereby helping to manage disease progression in patients facing challenging diagnoses. It is crucial to note that Everotas should only be administered under the supervision of a qualified healthcare professional, as it may cause side effects and interact with other medications. Patients should inform their doctor of any existing health conditions or treatments to ensure safe use. Regular monitoring is recommended to assess the effectiveness of the treatment and manage any potential adverse reactions. Everotas represents an important option for those dealing with advanced cancer, providing hope for improved outcomes when other treatments have failed. Always follow your healthcare provider's guidance for the best possible results with this therapy.
Quantity
Active Pharmaceutical Ingredient
Uses
• Everotas 0 25 mg tablet is primarily indicated for the treatment of advanced hormone receptor-positive, HER2-negative breast cancer in postmenopausal women. It is often used in conjunction with exemestane after previous treatments with letrozole or anastrozole have failed. Patients may experience various symptoms such as breast pain, changes in breast size, or unexplained weight loss. This medication helps manage the progression of the disease effectively.
• Everotas 0 25 mg tablet is also utilized in the management of neuroendocrine tumors (NET), which can arise in various parts of the body, including the lungs and pancreas. These tumors are rare but can significantly impact a patient's health. The use of Everotas 0 25 mg tablet helps to control tumor growth and alleviate associated symptoms. It provides an important treatment option for patients diagnosed with NET.
• In adult patients with kidney cancer, Everotas 0 25 mg tablet serves as a treatment option following the failure of prior therapies such as sunitinib or sorafenib. This medication can be crucial for managing the disease and improving the quality of life for those affected. Symptoms of kidney cancer can include fatigue, weight loss, and swelling, which Everotas 0 25 mg tablet helps to address. Its role in this context is vital for ongoing patient care.
• Everotas 0 25 mg tablet is indicated for the treatment of renal angiomyolipoma associated with Tuberous Sclerosis Complex (TSC) in adults who do not require immediate surgical intervention. This condition can lead to complications if not addressed properly. The medication aids in managing the growth of these tumors, providing a therapeutic option for patients with TSC. Everotas 0 25 mg tablet supports long-term management of this genetic condition.
Benefits
Everotas 0.25 mg Tablet is indicated to patients dealing with various cancers such as breast cancer, pancreatic cancer, lung cancer, kidney cancer and stomach/ intestinal cancer. Cancer of this type tends to spread quickly in other parts of the body. Benefits of Everotas 0.25 mg Tablet travels through the bloodstream and effectively destroys cancerous cells and other parts of the body. It works by decreasing the activity of the immune system of the body and prevents the rejection of the transplanted organ. Everotas 0.25 mg works by stopping the action of an abnormal protein that causes the multiplication of cancerous cells. In this way, it stops the spread of cancerous cells. Besides this, it is also effective in people with genetic disorders to treat some types of tumours in the brain or kidneys.
Side Effects
How Everotas 0.25 mg Tablet works may cause some side effects. If you experience any of these side effects contact your doctor as soon as possible. Your doctor may be able to suggest ways to manage or reduce the severity of these side effects.
Most Common Side Effects
• Infection
• Urinary issues
• Hypertension, rise in cholesterol or triglycerides
• Stomach pain, nausea, diarrhoea and/or constipation
• Headache
• Swelling in your legs or feet
Common Side Effects
• Swelling in legs and feet
• Blood in stools and urine
• Burning sensation during urination
• Mouth sores
• Headache
• Tiredness
• Nausea
How To Use
Side effects of Everotas 0.25 mg Tablet can be taken by mouth with or without food. Swallow the whole tablet with a glass of water. Do not crush, break, or chew the tablets. Take your dose around the same time every day. It is important to make sure you are taking the correct amount of medication every time. Before every dose, check that what you are taking matches what you have been prescribed. If you miss a dose and it has been less than 6 hours since your regular dose time, take it as soon as you remember. If it has been more than 6 hours, skip the dose. Do not take 2 doses at once to make up for a missed dose.
Safety Advice
• Alcohol: It is generally not recommended to drink alcohol while taking Side effects of Everotas 0.25 mg Tablet. It may increase the risk of liver damage. it is best to avoid alcohol or limit your alcohol consumption while taking any medication.
• Kidney: Everotas 0.25 mg Tablet is safe to use in patients with kidney disease. No dose adjustment of Everotas 0.25 mg is recommended.
• Breastfeeding: It is not recommended to breastfeed while taking Everotas 0.25 mg. Uses of Everotas 0.25 mg Tablet may pass into breast milk and harm the infant. If you are breastfeeding and taking Benefits of Everotas 0.25 mg Tablet, it is important to talk to your doctor about the possible risks and benefits of continuing to breastfeed. Your doctor will be able to help you make the best decision for you and your baby's health.
• Liver: Benefits of Everotas 0.25 mg Tablet should be used with caution in patients with liver disease. It is important that patients with liver disease closely monitor liver function while taking Everotas 0.25 mg and report any unusual symptoms or changes in liver function to their doctor. The dose of Everotas 0.25 mg may need to be adjusted in patients with liver disease.
• Pregnancy: Use of Benefits of Everotas 0.25 mg Tablet may be unsafe during pregnancy as animal studies indicate that it may harm the developing foetus. However, if you are pregnant or planning to become pregnant, it is important to talk to your doctor about the potential risks and benefits of taking Uses of Everotas 0.25 mg Tablet during pregnancy. Your doctor will be able to help you make the best decision for you and your baby's health.
• Driving: How Everotas 0.25 mg Tablet works may cause dizziness, fatigue, and difficulty concentrating and coordinating, which may affect your ability to drive a vehicle safely. It is important to follow your doctor's instructions and take necessary precautions such as avoiding driving a vehicle or operating heavy machinery if you suffer from the side effects of this How Everotas 0.25 mg Tablet works.